Stay updated on Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision label on the page was updated from v3.5.3 to v3.5.4. This represents a new version of the page content or documentation for the study record.
    Difference
    0.1%
    Check dated 2026-05-18T03:51:11.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page’s system/version footer was updated from “Revision: v3.5.2” to “Revision: v3.5.3”.
    Difference
    0.1%
    Check dated 2026-04-26T15:30:20.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-19T13:45:29.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Page revision label updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T18:38:49.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page, indicating a minor document update.
    Difference
    0.1%
    Check dated 2026-03-07T04:47:42.000Z thumbnail image
  9. Check
    107 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2; no substantive study content, endpoints, or locations were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T13:33:59.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page.